Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study-Reference-Cited by-同舟云学术

Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study

Published:2012-11-30 Issue:1 Volume:29 Page:13-21
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Inoue Yuichi¹,Hirata Koichi²,Uchimura Naohisa³,Kuroda Kenji⁴,Hattori Nobutaka⁵,Takeuchi Masahiro⁶

Affiliation:

1. Department of Somnology, Tokyo Medical University, Tokyo, Japan; Japan Somnology Center, Neuropsychiatric Research Institute Tokyo, Japan; Yoyogi Sleep Disorder Center, TokyoJapan

2. Department of Neurology, Dokkyo Medical University TochigiJapan

3. Department of Neuropsychiatry, Kurume University FukuokaJapan

4. Hannan Hospital OsakaJapan

5. Department of Neurology, Juntendo University TokyoJapan

6. Department of Clinical Medicine (Biostatistics & Pharmaceutical Medicine), School of Pharmacy, Kitasato University TokyoJapan

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2012.746217

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review;Case Reports in Critical Care;2022-09-05

2. Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome;Sleep Medicine;2021-09

3. Pharmacologic Treatment of Restless Legs Syndrome;Current Neuropharmacology;2021-03-15

4. Restless legs syndrome;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2021

5. Therapies for Restless Legs in Parkinson’s Disease;Current Treatment Options in Neurology;2019-11